The White Rabbit

The White Rabbit We are a small group of analysts providing free analysis on NZX listed securities.

Genesis Energy LimitedVerdict: HoldGNE have differentiated themselves from their competitors by retaining a strong cover...
26/09/2022

Genesis Energy Limited
Verdict: Hold
GNE have differentiated themselves from their competitors by retaining a strong coverage across dry year risk. This strength is likely to increase in the coming years as global warming increases hydro volatility and other energy companies race to brand themselves 100% renewable first. We see them as a great company to hold in tandem with another, hydro-reliant energy company but we have placed them on hold as they are currently trading at their target price.

Briscoe Group LimitedVerdict: AccumulateBGP continues to show healthy financials with strong FY22 results and an attract...
13/09/2022

Briscoe Group Limited
Verdict: Accumulate
BGP continues to show healthy financials with strong FY22 results and an attractive dividend. We question their continued growth in brick-and-mortar stores and the associated costs, given the strong online growth, but only time will tell if consumers return to stores or stay online. They are currently trading 14% below our target price, giving an appealing entry point for those willing to bear the wider market uncertainty.

AFT PHARMACEUTICALS LIMITEDVerdict: ReduceOverall AFT Pharmaceuticals showed healthy growth over FY22 and impressed inve...
03/09/2022

AFT PHARMACEUTICALS LIMITED
Verdict: Reduce
Overall AFT Pharmaceuticals showed healthy growth over FY22 and impressed investors with the announcement of their intent to pay dividends off of FY23. However, their recent Phase 2 failure with Pascomer reminds us that Maxigesic is their primary driving force, with other product lines supplementary at best. Ultimately, we still feel they are overpriced as a result of Covid and would like to see the price come off further before considering a purchase

23/06/2022

General Market: Reduce
It doesn't take an analyst to work out that we are in a bear market, the S&P 500 has dropped approximately 23% from its peak at the beginning of the year. Nor does it take an analyst to work out why, the Russia-Ukraine war has boosted inflation to its highest levels since 1990 and Central Banks are taking aggressive action to subdue it.

The real question is, where are we in the bear market? Have we just begun or are we at the bottom? Should I be selling, holding or buying? This is where we find out which analysts are worth their pay.

What have the previous bear markets looked like? If you look back to 1960 we can find 13 bear markets. Both the decline and length of these vary greatly but we find that average decline is 31% and the average length is 12 months. Considering we are only at 23% and 6 months, one would expect to see significantly more selling before the year it out.

What about the short term? We expect to see a slight recovery in the coming weeks. Sellers are fatigued and much of the major news has already been released and digested. It is likely that selling will pick back up again when companies begin issuing guidance and downgrading their earning.

While the variety of bear markets makes them inherently difficult to predict, we believe we are still on the decline (barring a near-term reprieve). Therefore we issue a reduce on the broader market.

Address

48 Shortland Street
Auckland
1010

Website

Alerts

Be the first to know and let us send you an email when The White Rabbit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share